Drawing for ELYSIA

USPTO serial 99676676

ELYSIA

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
QUEEN, ESTHER FELICIA
Law office
TMO LAW OFFICE 111

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ELYSIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services; Business and management consulting for healthcare providers and related businesses; Pharmaceutical cost management services and drug utilization review services; Health care cost review; Vendor management services for healthcare facilities; Consulting services in the cost management of health care; Marketing research services; Business strategic planning services; Collection and analysis of healthcare quality data for business purposes; Providing information and analysis in the fields of economics and business; Economic forecasting analysis for business purposes; Consumer strategy business consulting in the fields of marketing, sales, operation, and product design particularly specializing in the use of analytic models for the understanding and predicting of consumer, business, and retail market trends and actions; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Analysis of market research data and statistics; Statistical evaluations of marketing data; Providing economic consultation in the field of healthcare and pharmaceuticals; Business data analysis services in the field of healthcare and pharmaceuticals; Public policy consultancy in the field of healthcare and pharmaceuticalsACTIVESep 23, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 23, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Oct 23, 2026CNSLSUSPENSION LETTER WRITTEN—
Sep 29, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 29, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 29, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2026DOCKASSIGNED TO EXAMINER—
Jun 28, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 1, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance